SCRI Oncology Partners (formerly Tennessee Oncology) — Nashville, Tennessee

SCRI Oncology Partners (formerly Tennessee Oncology) is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

SCRI Oncology Partners (formerly Tennessee Oncology) has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Advanced or Metastatic NRAS-mutant Melanoma, Advanced or Metastatic Solid Tumors.

Sponsors: Erasca, Inc..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI Oncology Partners (formerly Tennessee Oncology)?

SCRI Oncology Partners (formerly Tennessee Oncology) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI Oncology Partners (formerly Tennessee Oncology) conducted?

SCRI Oncology Partners (formerly Tennessee Oncology) has 2 clinical trials on record, with 2 currently active. Their work covers Advanced or Metastatic NRAS-mutant Melanoma, Advanced or Metastatic Solid Tumors.

Is SCRI Oncology Partners (formerly Tennessee Oncology) accredited by Crixeo Health?

SCRI Oncology Partners (formerly Tennessee Oncology) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI Oncology Partners (formerly Tennessee Oncology)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.